Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation

Abstract

Src-specific activity has been reported to be elevated in a high percentage of colon cancer cell lines and tumors, but the underlying mechanisms are largely unknown. In this study, we report that, in the seven cancer cell lines tested, Src-specific activity was elevated (5.2- to 18.7-fold) relative to normal colon cells (FHC). This activation of Src correlated with reduced phosphorylation at Y530 of Src, whereas there was no significant change in the level of phosphorylation at Y419. The membrane tyrosine phosphatase activity for a Src family-specific phosphopeptide substrate FCP (Fyn COOH-terminal peptide phosphorylated by Csk) was greatly increased in the cancer cells and was attributed to PTP1B in most of the cell lines. Membrane PTP1B protein levels were also greatly increased. Overexpression of PTP1B increased Src specific activity in colon cancer cells by reducing phosphorylation at Y530 of Src. It also increased anchorage-independent cell growth and this increase was blocked by the Src inhibitor PP2 and Src small interfering RNA (siRNA). Down-regulating PTP1B activity by PTP1B inhibitor CinnGEL 2Me or knocking down PTP1B using siRNA also reduced Src kinase activity and colony formation ability of colon cancer cells. PTP1B siRNA reduced tumor growth in nonobese diabetic/severe combined immunodeficient mice. This study suggests that (a) PTP1B can act as an important activator of Src in colon cancer cells via dephosphorylation at Y530 of Src and (b) elevated levels of PTP1B can increase tumorigenicity of colon cancer cells by activating Src. [Cancer Res 2007;67(21):10129–37]

Overview

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-4338

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 51 references

Cited by

See all 177

Metadata

Authors
Zhu, S., Bjorge, J. D., & Fujita, D. J.
Affiliations
University of Calgary (CA)
Venue
Cancer Research
Published
2007-11-01
Volume
67
Issue
21
Pages
10129-10137
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2132926900
Cited by
168
References
51
Citations by year
2026: 4 · 2025: 5 · 2024: 1 · 2023: 10 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 6 · 2018: 6 · 2017: 10 · 2016: 13 · 2015: 12 · 2014: 9 · 2013: 11 · 2012: 8
FWCI
3.95
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
PTP1B, Src kinase activation, colon cancer, protein tyrosine phosphatase, anchorage-independent growth, tumorigenicity, PP2, siRNA knockdown, tumor growth in nude mice
MeSH terms
Animals, Colonic Neoplasms, Enzyme Activation, Humans, Male, Phosphorylation, Mice, SCID, src-Family Kinases, RNA, Small Interfering, Cell Line, Tumor, Cell Proliferation, Proto-Oncogene Proteins c-fyn, Mice, Protein Tyrosine Phosphatase, Non-Receptor Type 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation. https://app.cochat.ai/papers/10.1158/0008-5472.can-06-4338
The paper
Zhu, S., Bjorge, J. D., & Fujita, D. J. (2007). PTP1B Contributes to the Oncogenic Properties of Colon Cancer Cells through Src Activation. Cancer Research. https://doi.org/10.1158/0008-5472.can-06-4338

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.